🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Efficacy and Safety of the Ophthalmic Solution PRO-087 versus Systane ® Ult...
Status
Completed
Location
Fernando Rodriguez Sixtos Higuera
Start Date
2016-10-13
Trial ID
NCT03223909
Treatments Being Tested
Open-label study of an investigational product (IP), QLS-101, with 28-day e...
Status
Completed
Location
Duke Eye Center
Start Date
2022-11-23
Trial ID
NCT05495269
Treatments Being Tested
Congenital plasminogen deficiency causes impaired wound healing and growth ...
Status
Unknown
Location
University of Saskatchewan
Start Date
2022-12-15
Trial ID
NCT05404932
Treatments Being Tested
The primary objectives of the study are to evaluate the safety and effect o...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2014-07
Trial ID
NCT02245516
Treatments Being Tested
Glaucoma is the leading cause of irreversible blindness worldwide. Previous...
Status
Terminated
Location
University of California, San Francisco
Start Date
2022-10-10
Trial ID
NCT05273385
Treatments Being Tested
Compare the antihypertensive efficacy of two methods for instilling Xalatan...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00283764
Treatments Being Tested
Presbyopia is a condition where the eyes cannot focus a clear image on the ...
Status
Completed
Location
Shanxi Eye Hospital
Start Date
2025-09-04
Trial ID
NCT07151612
Treatments Being Tested
The primary purpose of this study is to determine the efficacy and safety o...
Status
Completed
Location
Sall Research Medical Center
Start Date
2014-05
Trial ID
NCT02163824
Treatments Being Tested
Double-masked, uncontrolled, multi-center, study in which participants will...
Status
Completed
Location
Colorado Retina Associates
Start Date
2018-04-26
Trial ID
NCT03479372
Treatments Being Tested
This is a 30-Day, multi-site, single-masked, bilateral, active- controlled,...
Status
Completed
Location
Vue Optical Boutique
Start Date
2023-02-23
Trial ID
NCT05661851
Treatments Being Tested